Raising Awareness for World Multiple Sclerosis Day
In honor of World MS Day on May 30, 2023, Yale Department of Neurology Chair and neuro-immunologist David Hafler, MD spoke with NBC Connecticut on the importance of early detection of MS, advances in effective therapies, and improvements in prognosis over the last 30 years.Source: NBC Connecticut
Study Suggests Retina Represents System for Investigating Therapeutic Approaches in Neurodegenerative Diseases
The findings provide evidence that the retina, the site of damage in advanced macular degeneration—the leading cause of blindness in elderly patients—is also a source for knowledge about treating neurodegenerative diseases.
A Staring Spell
Hal Blumenfeld, MD, PhD, Yale School of Medicine professor of neurology and director of the Yale Clinical Neuroscience Imaging Center, describes the journey of validating an animal for measuring behavioral response during absence epilepsy, understanding the neuronal basis for the condition, and the path toward identifying targeted therapies.Source: Yale Scientific
Study Finds Sleeping Pill Can Reduce Proteins Linked to Alzheimer's Disease
A recent study in "Annals of Neurology" suggests that sleeping pill, suvorexant (Belsomra), may decrease the levels of two key proteins linked with Alzheimer's disease. While the study is promising, Yale's Amran Fesharaki-Zadeh, MD, PhD notes that further clinical trials are needed to understand this connection.Source: healthline
Nowak Receives Impact Award
The Myasthenia Gravis Foundation of America (MGFA) has awarded its Impact Award to Richard Nowak, MD for his exceptional leadership, collaboration, innovation, and dedication to advancing the mission of the MGFA. Dr. Nowak was formally recognized at the 2023 MGFA National Patient Conference in New Orleans, La.
Migraine: A Neurological Condition That's Not Just in Your Head
In this video, Associate Professor of Neurology Jason Sico, MD, MHS describes the unique symptoms that set migraine apart as not being a “normal” headache and as a condition that profoundly affects quality of life. Dr. Sico also notes new developments in medications and other treatment options, and not only encourages patients to speak openly with their doctor, but also for doctors to take migraine seriously.Source: Yale Medicine YouTube
Yale School of Medicine researchers study ‘magic mushroom’ treatment for migraines
Christopher Gottschalk, MD, professor and chief of the division of general neurology at the Yale School of Medicine discusses research led by Emmanuelle Schindler, MD on the therapeutic effects of psilocybin on headache disorders.Source: WTNH News 8
Yale Research on Psychedelics Gives Hope to Headache Disorder Community
Medical Director of the Headache Center of Excellence at the West Haven VA Medical Center and Assistant Professor of Neurology Emmanuelle Schindler, MD, PhD is the only researcher in the United States studying psychedelics in headache disorders. Her pioneering research on the therapeutic effects of psilocybin on disorders such as cluster headache and partnership with a patient support group is giving hope to a misunderstood and misdiagnosed patient population.
Yale Team Cycles with Parkinson’s Foundation
On February 25, 2023, people with Parkinson’s, caregivers, allies, and healthcare providers from the Yale Comprehensive Parkinson's Disease Program participated in an indoor cycling event at CycleBar in West Hartford to raise awareness and funds for the Parkinson's Foundation.
MRI FOR ALL: Portable low-field scanners could revolutionize medical imaging in nations rich and poor—if doctors embrace them
In an interview with Science magaine, Yale's Kevin Sheth, MD says that the smaller size, versatility, and low cost of the Swoop portable MRI by Hyperfine has the potential to revolutionize medical imaging in the United States and abroad. Winning over physicians and patients is the next step in expanding the machine's use in clinical settings.Source: Science
Santiago Clocchiatti-Tuozzo, MD Honored with Bernard J. Tyson Career Development Award and Stroke Underrepresented Racial and Ethnic Groups Travel Grant
The American Heart Association has honored postdoctoral research fellow Santiago Clocchiatti-Tuozzo, MD with both the Bernard J. Tyson Career Development Award and the Stroke Underrepresented Racial and Ethnic Groups Travel Grant for excellence in neurology and cerebrovascular disease research.
Daniela Renedo, MD Wins American Heart Association Stroke Basic Science Award
The American Heart Association has honored Daniela Renedo, MD a postdoctoral fellow in the departments of Neurosurgery and Neurology, with the Stroke Basic Science Award for excellence in cerebrovascular disease research.
Significance of Relaunched Patient Registry for Myasthenia Gravis Research: Richard Nowak, MD, MS
the Myasthenia Gravis Foundation of America (MGFA) partnered with Alira Health to re-launch its MGFA Global MG Patient Registry. Yale assistant professor Richard Nowak, MD, MGFA’s chief medical advisor, discusses the importance of this registry, which allows MG patients to report their symptoms on a secure platform and informs future clinical trials and advances in treatment.Source: NeurologyLive